PMS-DEXAMETHASONE 4 MG — DIN 01964070
DEXAMETHASONE : 4 MG · PHARMASCIENCE INC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is PMS-DEXAMETHASONE?
PMS-DEXAMETHASONE 4 MG contains DEXAMETHASONE : 4 MG. It is listed in the Health Canada Drug Product Database under DIN 01964070, held by PHARMASCIENCE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 11-Oct-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Dexamethasone cost around the world?
Dexamethasone is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 15 | 101 | USD███.██ |
| Greece | producer price (ex-factory) | 61 | 61 | EUR███.██ |
| Saudi Arabia | public | 18 | 18 | SAR███.██ |
| United Kingdom | hospital | 16 | 16 | GBP███.██ |
| Bahrain | retail (max) | 11 | 14 | BHD███.██ |
| Morocco | PPV (public price) | 6 | 12 | MAD███.██ |
| South Africa | single exit price | 12 | 12 | ZAR███.██ |
| Czechia | max producer price (ex-factory) | 6 | 10 | CZK███.██ |
| Luxembourg | reimbursement | 9 | 9 | EUR███.██ |
| United Arab Emirates | public | 8 | 8 | AED███.██ |
| Australia | ex-manufacturer | 2 | 8 | AUD███.██ |
| Austria | KVP (Kassenverkaufspreis) | 3 | 5 | EUR███.██ |
| Hungary | producer price (ex-factory) | 1 | 1 | HUF███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
276 pack listings across 169 brand entries and 12 price bases, refreshed 08 Sep 2026. Ranges span every Dexamethasone pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Dexamethasone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
17 holders have a Canadian DIN containing Dexamethasone, across 42 DINs, of which 13 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PHARMASCIENCE INC | 7 | 4 | PMS-DEXAMETHASONE, PMS-DEXAMETHASONE ELIXIR, PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML, PMS-DEXAMETHASONE SOD PHOSPHATE INJ 4MG/ML | Sourceable in Canada |
| OMEGA LABORATORIES LIMITED | 3 | 3 | DEXAMETHASONE OMEGA UNIDOSE, DEXAMETHASONE-OMEGA | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 4 | 2 | DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP, DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML, DEXAMETHASONE SODIUM PHOSPHATE INJECTION SDZ | Sourceable in Canada |
| APOTEX INC | 2 | 2 | APO-DEXAMETHASONE | Sourceable in Canada |
| ODAN LABORATORIES LTD | 1 | 1 | ODAN-DEXAMETHASONE ELIXIR | Sourceable in Canada |
| STERIMAX INC | 1 | 1 | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP | Sourceable in Canada |
| PHARMEL INC | 5 | 0 | PHL-DEXAMETHASONE | No marketed DIN |
| JUNO PHARMACEUTICALS CORP. | 3 | 0 | DEXAMETHASONE, DEXAMETHASONE UNIDOSE | No marketed DIN |
| MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | 3 | 0 | DECADRON PHOSPHATE INJ 4MG/ML, DECADRON TAB 0.5MG, DECADRON TAB 4MG | No marketed DIN |
| VALEANT CANADA LP / VALEANT CANADA S.E.C. | 3 | 0 | DEXASONE 0.5MG, DEXASONE 0.75MG, DEXASONE 4MG | No marketed DIN |
| ORGANON TEKNIKA CANADA INC. | 2 | 0 | HEXADROL PHOSPHATE INJ 10MG/ML, HEXADROL PHOSPHATE INJ 4MG/ML | No marketed DIN |
| STRIDES PHARMA CANADA INC | 2 | 0 | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 4 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Dexamethasone |
|---|---|
| ATC code | H02AB02 |
| AHFS class | 68:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01964070 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1964070 |
| Brand name | PMS-DEXAMETHASONE |
| Generic / active ingredient | DEXAMETHASONE : 4 MG |
| Market authorization holder | PHARMASCIENCE INC |
| Health Canada schedule | Prescription |
| ATC code | H02AB02 |
| ATC anatomical main group | H — Systemic hormonal preparations |
| ATC therapeutic subgroup | H02AB |
| Current status | MARKETED |
| Status date | 11-Oct-2023 |
| Original market date | 1996-09-05 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Dexamethasone in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by STERIMAX INC (Tier 3 shortage DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP" aria-label="Actual Tier 3 shortage DEXAMETHASONE SODIUM P), last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
13 of 42 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-DEXAMETHASONE | 0.5 MG | TABLET | APOTEX INC | MARKETED | 02261081 |
| APO-DEXAMETHASONE | 4 MG | TABLET | APOTEX INC | MARKETED | 02250055 |
| DEXAMETHASONE OMEGA UNIDOSE | 10 MG / 1 ML | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | 02387743 |
| DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP | 10 MG / 1 ML | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | 00874582 |
| DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML | 4 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 00664227 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP | 4 MG/ML | SOLUTION | STERIMAX INC | MARKETED | 01977547 |
| DEXAMETHASONE-OMEGA | 4 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | 02204266 |
| DEXAMETHASONE-OMEGA | 10 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | 02204274 |
| ODAN-DEXAMETHASONE ELIXIR | 0.5 MG / 5 ML | ELIXIR | ODAN LABORATORIES LTD | MARKETED | 02528584 |
| PMS-DEXAMETHASONE | 0.5 MG | TABLET | PHARMASCIENCE INC | MARKETED | 01964976 |
2 · Same class — other molecules in ATC H02AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Dexamethasone | APO-DEXAMETHASONE · DECADRON PHOSPHATE INJ 4MG/ML · DECADRON TAB 0.5MG · DECADRON TAB 4MG · +24 more | 42 | 13 | Yes |
| Methylprednisolone | DEPO-MEDROL · MEDROL · METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP · METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(80MG/ML WITH PRESERVATIVE) · +7 more | 34 | 13 | Yes |
| Hydrocortisone | A-HYDROCORT INJ 1000MG/8ML · A-HYDROCORT INJ 100MG/2ML · A-HYDROCORT INJ 250MG/2ML · A-HYDROCORT INJ 500MG/4ML · +6 more | 18 | 8 | Yes |
| Prednisone | ALTI-PREDNISONE TAB 5MG · APO PREDNISONE TAB 1MG USP · APO PREDNISONE TAB 50MG · APO PREDNISONE TAB 5MG · +11 more | 19 | 5 | Yes |
| Triamcinolone | ARISTOCORT - SYR ORL 0.4MG/ML · ARISTOCORT - TAB 4MG · ARISTOCORT FORTE - LIQ IA IM ISY 40MG/ML · ARISTOCORT FORTE INJ 40MG/ML · +15 more | 21 | 3 | Yes |
| Betamethasone | BETAJECT · BETNESOL TAB 0.5MG · BETNESOL TABLETS · CELESTONE REPETABS 1MG · +2 more | 6 | 1 | Yes |
| Prednisolone | NOVO-PREDNISOLONE 5MG · PEDIAPRED · PEDIAPRED - LIQ 6.7MG/5ML · PMS-PREDNISOLONE | 4 | 1 | Yes |
| Cortisone | CORTISONE ACETATE · CORTONE SUS 50MG/ML · CORTONE TAB 25MG · CORTONE TAB 5MG | 4 | 1 | Yes |
| Prednisone, Combinations | METRETON TAB | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC H02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| H02AA | Fludrocortisone | 3 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PMS-DEXAMETHASONE called?
The same molecule, Dexamethasone, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Ozurdex | Latin | Australia, Bahrain, South Africa |
| DECADRON | Latin | Bahrain, Morocco |
| DEXAMETHASONE MYLAN | Latin | Morocco |
| Dexmethsone | Latin | Australia |
| APO-DEXAMETHASONE | Latin | Bahrain |
| DEXAMETHASONE KRKA | Latin | Czechia |
| DEXAMETHASONE NORIDEM | Latin | Czechia |
| DEXAMETHASONE ZENTIVA | Latin | Czechia |
| DUCRESSA | Latin | Bahrain, Saudi Arabia |
| FORTECORTIN | Latin | Czechia |
| Maxidex | Latin | Bahrain, South Africa |
| Maxitrol | Latin | Saudi Arabia, South Africa |
| ORADEXON | Latin | Morocco |
| ORADEXON ELIXIR | Latin | Morocco |
| TOBRADEX | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.